Skip to main content
Study finds immunotherapy beneficial in HIV-related cancer

Findings from a study in the journal JAMA Oncology showed immunotherapy's potential as a treatment for the HIV-associated cancer Kaposi's sarcoma in HIV-positive patients. Data indicated a 67% response rate when checkpoint inhibitors were given to the patients.

Full Story: